Arthritis Trial Finder

3D MR Versus 3D CT for Glenohumeral Arthritis

Study Purpose

This study aims to assess the efficacy of three-dimensional magnetic resonance (MR) compared to three-dimensional computed tomography (CT) imaging. This proposed study is a prospective, unrandomized, single-blinded, self-controlled, and single-armed diagnostic radiological evaluation study.

Recruitment Criteria

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Accepts Healthy Volunteers
No

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Study Type
Interventional
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Patients suffering from glenohumeral OA; - Radiographic evidence of severe glenoid erosion; - Indication for TSA based on clinical exam; - Patient is willing to participate by complying with pre-operative visit requirements; - Patient is willing and able to review and sign a study informed consent form.

Exclusion Criteria:

  • - Prior arthroplasty at the affected shoulder; - Patients with inflammatory arthritis; - Patients with post-capsulorrhaphy arthritis; - Patients with post-traumatic arthritis; - Patients with rotator cuff tear arthropathy; - Patients exhibiting a lack of physical or mental ability to perform or comply with the study procedures; - Patients who are pregnant; - Patients with implanted medical devices that are contraindicated to exposure up to a 3.0-tesla magnetic field.

Trial Details

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

Trial ID:
NCT03379545

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Phase
N/A

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Lead Sponsor
New York University School of Medicine

The person who is responsible for the scientific and technical direction of the entire clinical study.

Principal Investigator
Joseph D Zuckerman, MD
Principal Investigator Affiliation New York University School of Medicine

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Agency Class
Other
Overall Status Recruiting
Countries United States

The disease, disorder, syndrome, illness, or injury that is being studied.

Conditions
Arthritis, Glenohumeral Osteoarthritis

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

New York University School of Medicine, New York, New York

Status

Recruiting

Address

New York University School of Medicine

New York, New York, 10016

Site Contact

Ariel Aponte

ariel.aponte@nyumc.org

212-460-0176

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.

Getting involved in science in one form or another allows you and your loved ones to help scientists find better treatments for others in the future. Clinical trials and disease registries are part of clinical research and are at the heart scientific discovery.

You have the power to influence the research conducted by scientists in other way too, like taking surveys or serving on committees. Below are current opportunities: